BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29990852)

  • 1. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
    Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
    Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells.
    Środa-Pomianek K; Michalak K; Palko-Łabuz A; Uryga A; Świątek P; Majkowski M; Wesołowska O
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
    Takács D; Csonka Á; Horváth Á; Windt T; Gajdács M; Riedl Z; Hajós G; Amaral L; Molnár J; Spengler G
    Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells.
    Palko-Łabuz A; Środa-Pomianek K; Wesołowska O; Kostrzewa-Susłow E; Uryga A; Michalak K
    Biomed Pharmacother; 2019 Jan; 109():1511-1522. PubMed ID: 30551403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic and multidrug resistance reversal activity of phenothiazine derivative is strongly enhanced by theobromine, a phytochemical from cocoa.
    Środa-Pomianek K; Michalak K; Palko-Łabuz A; Poła A; Dzięgiel P; Puła B; Świątek P; Wesołowska O
    Eur J Pharmacol; 2019 Apr; 849():124-134. PubMed ID: 30721703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of phenothiazine derivatives on intracellular accumulation of cationic cyanine dye DiOC6(3) in LoVo-DX cells.
    Pola A; Mosiadz D; Saczko J; Modrzycka T; Michalak K
    Anticancer Res; 2013 Mar; 33(3):857-63. PubMed ID: 23482754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells.
    Wesołowska O; Michalak K; Błaszczyk M; Molnár J; Środa-Pomianek K
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32260260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
    Wesołowska O; Wiśniewski J; Sroda-Pomianek K; Bielawska-Pohl A; Paprocka M; Duś D; Duarte N; Ferreira MJ; Michalak K
    J Nat Prod; 2012 Nov; 75(11):1896-902. PubMed ID: 23137376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline.
    Broggini M; Grandi M; Ubezio P; Geroni C; Giuliani FC; D'Incalci M
    Biochem Pharmacol; 1988 Dec; 37(23):4423-31. PubMed ID: 3202888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein.
    Wang H; Deng Z; Chen X; Cai J; Ma T; Zhong Q; Li R; Li L; Li T
    Med Sci Monit; 2019 Mar; 25():2169-2178. PubMed ID: 30904920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative alterations induced in vitro by the photodynamic reaction in doxorubicin-sensitive (LoVo) and -resistant (LoVoDX) colon adenocarcinoma cells.
    Kulbacka J; Chwilkowska A; Bar J; Pola A; Banas T; Gamian A; Saczko J
    Exp Biol Med (Maywood); 2010 Jan; 235(1):98-110. PubMed ID: 20404024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of new oxicam derivatives on efflux pumps overexpressed in resistant a human colorectal adenocarcinoma cell line.
    Środa-Pomianek K; Wesołowska O; Szczęśniak-Sięga B; Puła B; Dzięgiel P; Maniewska J; Malinka W; Palko-Łabuz A; Michalak K
    Anticancer Res; 2015 May; 35(5):2835-40. PubMed ID: 25964564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts.
    Calcabrini A; Arancia G; Marra M; Crateri P; Befani O; Martone A; Agostinelli E
    Int J Cancer; 2002 May; 99(1):43-52. PubMed ID: 11948490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
    Toffoli G; Corona G; Gigante M; Boiocchi M
    Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
    Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
    Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
    Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
    Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Irinotecan and Melatonin with the Natural Compounds Wogonin and Celastrol for Colon Cancer Treatment.
    Radajewska A; Moreira H; Bęben D; Siwiela O; Szyjka A; Gębczak K; Nowak P; Frąszczak J; Emhemmed F; Muller CD; Barg E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms.
    Locatelli L; Cazzaniga A; Fedele G; Zocchi M; Scrimieri R; Moscheni C; Castiglioni S; Maier JA
    Curr Issues Mol Biol; 2021 May; 43(1):163-175. PubMed ID: 34067290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activity of baicalein and luteolin studied in colorectal adenocarcinoma LoVo cells and in drug-resistant LoVo/Dx cells.
    Palko-Labuz A; Sroda-Pomianek K; Uryga A; Kostrzewa-Suslow E; Michalak K
    Biomed Pharmacother; 2017 Apr; 88():232-241. PubMed ID: 28110189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.